Avicanna Inc collaborates with the University of Toronto to expand its epilepsy research program

Avicanna Inc (TSX:AVCN, OTCQX:AVCNF) announced that it has expanded its research collaboration in the field of epilepsy through a new partnership with the University of Toronto and Dr. Mac Burnham’s research team to explore the efficacy of Avicanna’s proprietary formulations in preclinical disease treatment models.

The commercial-stage biopharmaceutical company said Dr. Mac Burnham’s team will explore the efficacy of Avicanna’s drug candidates and its proprietary combination of cannabinoids, including AVCN319302, in a preclinical model for seizures.

“The combination of real-world evidence and ongoing research collaborations allows us to further develop our pharmaceutical pipeline and advance our drug candidate in the area of ​​epilepsy,” said Vice President of Scientific Affairs and medical officers of Avicanna, Dr. Karolina Urban, in a press release.

READ: Avicanna closes strategic non-brokered private placement offering of units for aggregate gross proceeds of approximately $2.782 million

Avicanna noted that the research collaboration will also evaluate the anti-epileptic properties of rare cannabinoids in isolation and in combination, and will be supported by the company’s current medical cannabis sales.

Dr. Burnham is Professor Emeritus of Pharmacology and Toxicology at the University of Toronto’s Temerty School of Medicine and, with his more than 150 publications, he has contributed greatly to the advancement of anti-epileptic therapies, according to the society.

Avicanna is an international, commercial-stage biopharmaceutical company focused on advancing and commercializing evidence-based cannabinoid products for the global medical and pharmaceutical market segments.

The company has an established scientific platform including R&D and clinical development which has led to the commercialization of over 30 products in various market segments.

Contact Sean at [email protected]

About Michael Bill

Check Also

Staff moves at Our Lady of the Lake Children’s Health, Louisiana Small Business Development Center, City Year Baton Rouge | Company

Red Stick Dr Yash Shah joined Health of the children of Notre-Dame du Lac as …